Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV MMR vaccine study for prevention or severity reduction of COVID-19 in frontline healthcare workers
RBR-2xd6dkjPhase 4Recruiting
- Sponsor
- Universidade Federal de Santa Catarina
- Start
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing MMR vaccine with Placebo (2 arms). Started Jul 2020; status: recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-2xd6dkj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2xd6dkj.